Literature DB >> 2955050

Inhibition of B lymphocyte activation by interferon-gamma.

D S Reynolds, W H Boom, A K Abbas.   

Abstract

Helper/inducer T cell clones specific for protein antigens and class II MHC determinants consist of two nonoverlapping subsets. One (called Th1) secretes IL 2 and IFN-gamma and the other (Th2) produces BSF1 upon stimulation with antigen or polyclonal activators. By using hapten-binding normal B cells and the B lymphoma line WEHI-279 as assays for B cell helper (maturation) factors, we have shown that Th2 clone supernatants (SN) induce differentiation to antibody secretion, whereas Th1 SN do not. The failure of Th1 SN to activate B cells is due to inhibitory effects of IFN-gamma, because it can be reversed by a neutralizing monoclonal antibody specific for IFN-gamma. Thus, in the presence of this antibody, even Th1 SN stimulate B cell maturation maximally. Conversely, recombinant IFN-gamma inhibits proliferation and differentiation of B cells induced by active Th2 SN. These results demonstrate that IFN-gamma is a potent inhibitor of B lymphocyte activation and can be distinguished from growth and maturation-inducing helper factors that are produced by both subsets of helper T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955050

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Cytokines and the regulation of tolerance.

Authors:  J L Ferrara
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Nature and specificity of the required protective immune response that develops postchallenge in mice vaccinated with the 19-kilodalton fragment of Plasmodium yoelii merozoite surface protein 1.

Authors:  Jiraprapa Wipasa; Huji Xu; Morris Makobongo; Michelle Gatton; Anthony Stowers; Michael F Good
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Generalized immunological decline during long-term experimental infection with Mycobacterium avium.

Authors:  Brad Gilbertson; Christina Cheers
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Impaired regulation of natural killer cells in immunoglobulin synthesis by peripheral blood mononuclear cells from patients with ulcerative colitis.

Authors:  T Kawase; K Kusugami; H Matsunaga; T Matsuura; K Morise
Journal:  Gastroenterol Jpn       Date:  1990-10

5.  Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms.

Authors:  Y Zhan; Z Liu; C Cheers
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Differential induction of interferon gamma gene expression after activation of CD4+ T cells by conventional antigen and Mls superantigen.

Authors:  R Patarca; F Y Wei; M V Iregui; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

7.  In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis.

Authors:  Sergio Arce; Hesham F Nawar; Gwendolin Muehlinghaus; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

8.  T-cell lymphokine response to orally administered proteins during priming and unresponsiveness.

Authors:  G F Hoyne; M G Callow; J Kuhlman; W R Thomas
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  T-cell responses to orally administered antigens. Study of the kinetics of lymphokine production after single and multiple feeding.

Authors:  G F Hoyne; W R Thomas
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

10.  Hemolysin-producing Listeria monocytogenes affects the immune response to T-cell-dependent and T-cell-independent antigens.

Authors:  C M Hage-Chahine; G Del Giudice; P H Lambert; J C Pechere
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.